Aardvark Therapeutics, Inc. Share Price & Technical Analysis

AARD · $3.81 (-4.03%)

Healthcare / Biotechnology

AI Score 23 · Bearish

$3.81

-4.03%

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Price chart

Seasonality

Jun has 1 positive and 1 negative years (last 2 years shown)

-5% return in Jun, 26% avg return in past 3 year Jun month.

-27% return in 2026, 30% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-2%-2%-37%42%-23%-5%-27%
25-16%-42%48%-5%26%-12%-31%58%-22%-7%32%30%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 23/100

Bearish · Downtrend · Weak

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$84.21M

P/E ratio

52W high

$17.94

52W low

$3.35

Volume

1,47,285

Related stocks in Healthcare

Frequently asked questions

What is Aardvark Therapeutics, Inc. share price today?
Aardvark Therapeutics, Inc. (AARD) last traded around $3.81 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does AARD have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for AARD. Download the app for real-time alerts.
How can I analyze Aardvark Therapeutics, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro